|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,732.80 INR | -1.51% |
|
-1.85% | -15.99% |
| May. 30 | Jefferies Adjusts Alkem Laboratories' Price Target to INR4,460 From INR4,580, Keeps at Underperform | MT |
| May. 29 | Alkem Laboratories Limited, Q4 2025 Earnings Call, May 29, 2025 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability (Composite) | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
| 6.7B | ||||||
| 706B | ||||||
| 376B | ||||||
| 337B | ||||||
| 309B | ||||||
| 262B |
Select your edition
All financial news and data tailored to specific country editions
